title: Is there any place for oral anti-restenotic treatment in the era of drug eluting stents?
abstract: Are drug eluting stents destined to become the standard of care for all patients undergoing percutaneous coronary intervention, or are alternative therapeutic approaches preferable under certain circumstances?
authors.forename: A H
authors.initials: AH
authors.lastname: Gershlick
mesh_terms: D000284:Administration, Oral; D015906:Angioplasty, Balloon, Coronary / Q000379:methods; D000925:Anticoagulants / Q000008:administration & dosage*; D001026:Coronary Artery Bypass / Q000379:methods; D023903:Coronary Restenosis / Q000517:prevention & control*; D004343:Drug Implants; D006801:Humans; D015607:Stents
chemical_list: D000925:Anticoagulants; D004343:Drug Implants